BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Lexicor Medical Technologies, Inc. Release: Multi-Center Study Evaluates Use Of NeuroLex Indicator Report Service In ADHD Assessment


10/19/2005 5:13:18 PM

GREENVILLE, S.C., Sept. 28 /PRNewswire/ -- On Oct. 6, Lexicor Medical Technologies will make an important announcement related to regulations and clinical trials of the NeuroLex Indicator Report Service(SM) for Attention Deficit Hyperactivity Disorder (ADHD). This announcement has significant implications for the future of ADHD assessment.

You are invited to join us for this Internet presentation on Thursday, October 6, 2005, at 11:00 a.m. Eastern Standard Time.

What: Lexicor Internet Media Briefing (3-5 minutes in length) Who: Vince Colwell, Lexicor and Dr. Humberto Quintana, director of the Louisiana State University Health Science Center When: Thursday, October 6, 2005 at 11:00 a.m. EST Where: http://www.videonewswire.com/event.asp?id=30620 How: Via the Internet -- Simply log on to the Web at the above address

If you are unable to participate on Oct. 6, the presentation will be archived on the Web, or you can call Mike Crisp at 864-298-1430 to make other arrangements.

The NeuroLex Indicator Report Service(SM) for ADHD is the first scientifically-validated objective and non-invasive assessment aid based upon biological indicators rather than upon subjective pencil/paper tests. It is currently being used by medical providers -- primarily pediatricians -- across the country.

Please visit this Web site to make sure you have the software needed to participate: http://www.videonewswire.com/event.asp?id=30620

Video: http://www.videonewswire.com/event.asp?id=30620Lexicor Medical Technologies, LLC

CONTACT: Mike Crisp, +1-864-298-1430, or crisp@hendersonadv.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES